Market Cap 144.37M
Revenue (ttm) 0.00
Net Income (ttm) -140.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 1.41
Volume 2,660,200
Avg Vol 2,020,582
Day's Range N/A - N/A
Shares Out 158.65M
Stochastic %K 39%
Beta 2.29
Analysts Strong Sell
Price Target $5.03

Company Profile

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-t...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 902 8800
Website: fractyl.com
Address:
3 Van de Graaff Drive, Suite 200, Burlington, United States
BioRich
BioRich Jul. 16 at 8:39 PM
$GUTS Still massively bullish. #1 on our list and that doesn't appear to be changing anytime soon. Surprisingly, adding more on this pullback. Simple math...this kicks to a buck again (which I have no doubt it will...and beyond), you're up 17% on your trade. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers! $XBI $ALLR $ALUR $VERU
1 · Reply
stocksense2
stocksense2 Jul. 16 at 6:46 PM
$GUTS If positive news holds, will this be a buyout? And by who? Hmm...
1 · Reply
Jalal
Jalal Jul. 16 at 6:21 PM
$ALT added more today and im im still at $GUTS , Bio rich give me some love
1 · Reply
stocksense2
stocksense2 Jul. 16 at 5:23 PM
0 · Reply
Robert345
Robert345 Jul. 16 at 5:04 PM
$GUTS 100%
0 · Reply
2TrustHim
2TrustHim Jul. 16 at 3:21 PM
$GUTS I Got A GUT Feeling!!!
0 · Reply
dl42
dl42 Jul. 16 at 2:50 PM
$GUTS love this only has a $150M mkt cap!
0 · Reply
Sunnibouno
Sunnibouno Jul. 16 at 2:35 PM
$GUTS Any other pharmacy stock would be above $10.. with positive one-year results.. but $GUTS nooooooo.. WTF
0 · Reply
Crypto9999
Crypto9999 Jul. 16 at 2:20 PM
$GUTS GLP-1 drugs are changing the game for obesity and type 2 diabetes—but they don’t directly address the underlying metabolic dysfunction in the gut. That’s where Revita could fit in. GLP-1s help patients lose weight and control blood sugar, while Revita is designed to improve insulin sensitivity by targeting the duodenum. Together, they have the potential to provide a more complete treatment approach than either therapy alone. If combination therapies become the standard of care, Revita could be a significant value driver. 🚀🤑🤑🤑🤑🚀
0 · Reply
Crypto9999
Crypto9999 Jul. 16 at 2:12 PM
$GUTS Back over $1 coming(imo) Sellers drying up???
0 · Reply
Latest News on GUTS
Fractyl Health Transcript: Study result

Jul 15, 2026, 8:00 AM EDT - 2 days ago

Fractyl Health Transcript: Study result


Fractyl Health Press release: Study result

Jul 15, 2026, 8:00 AM EDT - 2 days ago

Fractyl Health Press release: Study result


Fractyl Health Slides: Study result

Jul 15, 2026, 8:00 AM EDT - 2 days ago

Fractyl Health Slides: Study result


Fractyl Health reports results from REMAIN-1 Midpoint Cohort

2026-07-15T10:05:54.000Z - 2 days ago

Fractyl Health reports results from REMAIN-1 Midpoint Cohort


Craig-Hallum bullish on Fractyl Health, initiates with a Buy

2026-07-01T13:10:37.000Z - 15 days ago

Craig-Hallum bullish on Fractyl Health, initiates with a Buy


Fractyl Health initiated with a Buy at Craig-Hallum

2026-07-01T11:30:11.000Z - 16 days ago

Fractyl Health initiated with a Buy at Craig-Hallum


Fractyl Health Transcript: AGM 2026

Jun 10, 2026, 12:00 PM EDT - 5 weeks ago

Fractyl Health Transcript: AGM 2026


Fractyl Health reports Q1 EPS 6c, consensus (16c)

2026-05-12T21:42:36.000Z - 2 months ago

Fractyl Health reports Q1 EPS 6c, consensus (16c)


Fractyl Health Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 2 months ago

Fractyl Health Earnings Call Transcript: Q1 2026


Fractyl Health Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 2 months ago

Fractyl Health Earnings release: Q1 2026


Fractyl Health Quarterly report: Q1 2026

May 12, 2026, 4:30 PM EDT - 2 months ago

Fractyl Health Quarterly report: Q1 2026


Fractyl Health Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 3 months ago

Fractyl Health Proxy statement: Proxy filing


Fractyl Health Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 3 months ago

Fractyl Health Proxy statement: Proxy filing


Fractyl Health Earnings Call Transcript: Q4 2025

Mar 24, 2026, 4:30 PM EDT - 4 months ago

Fractyl Health Earnings Call Transcript: Q4 2025


Fractyl Health Annual report: Q4 2025

Mar 24, 2026, 4:30 PM EDT - 4 months ago

Fractyl Health Annual report: Q4 2025


Fractyl Health Earnings release: Q4 2025

Mar 24, 2026, 4:30 PM EDT - 4 months ago

Fractyl Health Earnings release: Q4 2025


Fractyl Health Annual report: Q4 2025

Mar 24, 2026, 4:30 PM EDT - 4 months ago

Fractyl Health Annual report: Q4 2025


Fractyl Health completes randomization in REMAIN-1 cohort

2026-02-26T12:36:24.000Z - 5 months ago

Fractyl Health completes randomization in REMAIN-1 cohort


Biotech Alert: Searches spiking for these stocks today

2026-02-02T16:50:10.000Z - 5 months ago

Biotech Alert: Searches spiking for these stocks today


Biotech Alert: Searches spiking for these stocks today

2026-01-30T16:10:26.000Z - 5 months ago

Biotech Alert: Searches spiking for these stocks today


Fractyl Health price target lowered to $2 from $5 at BofA

2026-01-30T14:50:16.000Z - 5 months ago

Fractyl Health price target lowered to $2 from $5 at BofA


Fractyl Health Transcript: Study result

Jan 29, 2026, 8:00 AM EST - 6 months ago

Fractyl Health Transcript: Study result


Fractyl Health Press release: Study result

Jan 29, 2026, 8:00 AM EST - 6 months ago

Fractyl Health Press release: Study result


Fractyl Health Slides: Study result

Jan 29, 2026, 8:00 AM EST - 6 months ago

Fractyl Health Slides: Study result


Fractyl Health announces results from trial evaluating Revita

2026-01-29T12:21:38.000Z - 6 months ago

Fractyl Health announces results from trial evaluating Revita


Biotech Alert: Searches spiking for these stocks today

2026-01-27T17:16:01.000Z - 6 months ago

Biotech Alert: Searches spiking for these stocks today


Fractyl Health appoints Lara Smith Weber as CFO

2026-01-06T12:10:45.000Z - 6 months ago

Fractyl Health appoints Lara Smith Weber as CFO


Fractyl Health outlines strategic outlook for 2026

2026-01-05T12:21:09.000Z - 6 months ago

Fractyl Health outlines strategic outlook for 2026


Fractyl Health management to meet virtually with Needham

2025-12-10T21:21:05.000Z - 7 months ago

Fractyl Health management to meet virtually with Needham


Biotech Alert: Searches spiking for these stocks today

2025-12-05T17:20:11.000Z - 7 months ago

Biotech Alert: Searches spiking for these stocks today

PLRZ


Biotech Alert: Searches spiking for these stocks today

2025-12-04T17:10:59.000Z - 8 months ago

Biotech Alert: Searches spiking for these stocks today

PLRZ SMMT


Fractyl Health Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:30 PM EST - 8 months ago

Fractyl Health Earnings Call Transcript: Q3 2025


Fractyl Health Quarterly report: Q3 2025

Nov 12, 2025, 4:30 PM EST - 8 months ago

Fractyl Health Quarterly report: Q3 2025


Fractyl Health Earnings release: Q3 2025

Nov 12, 2025, 4:30 PM EST - 8 months ago

Fractyl Health Earnings release: Q3 2025


Fractyl Health Transcript: Study Update

Sep 26, 2025, 8:00 AM EDT - 10 months ago

Fractyl Health Transcript: Study Update


Fractyl Health Press release: Study Update

Sep 26, 2025, 8:00 AM EDT - 10 months ago

Fractyl Health Press release: Study Update


Fractyl Health Slides: Study Update

Sep 26, 2025, 8:00 AM EDT - 10 months ago

Fractyl Health Slides: Study Update


Fractyl Health Slides: Corporate Presentation

Sep 26, 2025, 7:00 AM EDT - 10 months ago

Fractyl Health Slides: Corporate Presentation


Fractyl Health Proxy statement: Proxy Filing

Aug 25, 2025, 8:00 AM EDT - 11 months ago

Fractyl Health Proxy statement: Proxy Filing


Fractyl Health Proxy statement: Proxy Filing

Aug 15, 2025, 8:00 AM EDT - 1 year ago

Fractyl Health Proxy statement: Proxy Filing


Fractyl Health Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Fractyl Health Earnings Call Transcript: Q2 2025


Fractyl Health Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Fractyl Health Quarterly report: Q2 2025


Fractyl Health Earnings release: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Fractyl Health Earnings release: Q2 2025


Fractyl Health Announces Proposed Public Offering

Aug 5, 2025, 4:15 PM EDT - 1 year ago

Fractyl Health Announces Proposed Public Offering


Fractyl Health Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Fractyl Health Earnings Call Transcript: Q1 2025


Fractyl Health Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Fractyl Health Earnings release: Q1 2025


Fractyl Health Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Fractyl Health Quarterly report: Q1 2025


Fractyl Health Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Fractyl Health Proxy statement: Proxy Filing


Fractyl Health Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Fractyl Health Proxy statement: Proxy Filing


Fractyl Health Registration statement: Registration Filing

Mar 13, 2025, 8:00 AM EDT - 1 year ago

Fractyl Health Registration statement: Registration Filing


Fractyl Health Earnings Call Transcript: Q4 2024

Mar 3, 2025, 4:30 PM EST - 1 year ago

Fractyl Health Earnings Call Transcript: Q4 2024


Fractyl Health Earnings release: Q4 2024

Mar 3, 2025, 4:30 PM EST - 1 year ago

Fractyl Health Earnings release: Q4 2024


Fractyl Health Annual report: Q4 2024

Mar 3, 2025, 4:30 PM EST - 1 year ago

Fractyl Health Annual report: Q4 2024


Fractyl Health Registration statement: Registration Filing

Mar 3, 2025, 7:00 AM EST - 1 year ago

Fractyl Health Registration statement: Registration Filing


Fractyl Health Earnings Call Transcript: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Fractyl Health Earnings Call Transcript: Q3 2024


Fractyl Health Earnings release: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Fractyl Health Earnings release: Q3 2024


Fractyl Health Quarterly report: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Fractyl Health Quarterly report: Q3 2024


BioRich
BioRich Jul. 16 at 8:39 PM
$GUTS Still massively bullish. #1 on our list and that doesn't appear to be changing anytime soon. Surprisingly, adding more on this pullback. Simple math...this kicks to a buck again (which I have no doubt it will...and beyond), you're up 17% on your trade. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers! $XBI $ALLR $ALUR $VERU
1 · Reply
stocksense2
stocksense2 Jul. 16 at 6:46 PM
$GUTS If positive news holds, will this be a buyout? And by who? Hmm...
1 · Reply
Jalal
Jalal Jul. 16 at 6:21 PM
$ALT added more today and im im still at $GUTS , Bio rich give me some love
1 · Reply
stocksense2
stocksense2 Jul. 16 at 5:23 PM
0 · Reply
Robert345
Robert345 Jul. 16 at 5:04 PM
$GUTS 100%
0 · Reply
2TrustHim
2TrustHim Jul. 16 at 3:21 PM
$GUTS I Got A GUT Feeling!!!
0 · Reply
dl42
dl42 Jul. 16 at 2:50 PM
$GUTS love this only has a $150M mkt cap!
0 · Reply
Sunnibouno
Sunnibouno Jul. 16 at 2:35 PM
$GUTS Any other pharmacy stock would be above $10.. with positive one-year results.. but $GUTS nooooooo.. WTF
0 · Reply
Crypto9999
Crypto9999 Jul. 16 at 2:20 PM
$GUTS GLP-1 drugs are changing the game for obesity and type 2 diabetes—but they don’t directly address the underlying metabolic dysfunction in the gut. That’s where Revita could fit in. GLP-1s help patients lose weight and control blood sugar, while Revita is designed to improve insulin sensitivity by targeting the duodenum. Together, they have the potential to provide a more complete treatment approach than either therapy alone. If combination therapies become the standard of care, Revita could be a significant value driver. 🚀🤑🤑🤑🤑🚀
0 · Reply
Crypto9999
Crypto9999 Jul. 16 at 2:12 PM
$GUTS Back over $1 coming(imo) Sellers drying up???
0 · Reply
Striving2bmore
Striving2bmore Jul. 16 at 11:49 AM
$GUTS zero device-related or procedure-related serious adverse effects reported in real world study
0 · Reply
Striving2bmore
Striving2bmore Jul. 16 at 11:40 AM
$GUTS the procedure is already available commercially in Germany and has CE Mark in UK and European Union. 
0 · Reply
Ked1977
Ked1977 Jul. 16 at 9:09 AM
$GUTS I hope this opens up better. Has drifted down to almost where it started yesterday morning before the good news. Rather than gaining long term investors they keep creating bag holders. They can’t get their positive new across because they burned people so badly in January and bag holders just want to get some of their money back. An endless cycle of losing investor confidence. I hope they can make it back to the $2 mark again.
0 · Reply
Ritschier
Ritschier Jul. 16 at 5:15 AM
$GUTS You're a guy who went from 150 kg down to about 124 kg with those wonder, billion-dollar weight-loss drugs - which is pretty awesome by itself. ​Sure, the side effects sucked and it was expensive as hell. ​Now imagine you stop the injections and go back to living like before. After 12 months, your scale says: 144 kg. ​Ouch. ​Not far from where you started. ​There goes the money - and the dream of being much healthier and finally shopping for clothes more easily. ​Well, let me introduce REVITA. ​Remember getting down to that awesome 124 kg? ​Without more injections and without more side effects, you might stay at a pretty fantastic 129.9 kg after that awesome 124 kg first round. And the idea is that you stay there. ​That's REVITA. ​Maybe you'll need to take another short nap every year or two to maintain the weight. But that might be all it takes compared to the futility of before. Ywah, that thing has a future. They just need to explain it in a way that everybody gets.
0 · Reply
BioTuesdays
BioTuesdays Jul. 15 at 10:11 PM
$GUTS has announced positive one-year results from its REMAIN-1 Midpoint Cohort reinforcing the potential of the Revita DMR System to be the first durable procedural therapy for post-GLP-1 weight maintenance. https://biotuesdays.com/2026/07/15/fractyl-reports-positive-one-year-remain-1-weight-maintenance-data/
0 · Reply
Ked1977
Ked1977 Jul. 15 at 8:39 PM
$GUTS. What a disappointing pull back after that news. Just shows you the market still doesn’t trust this company.
0 · Reply
NSAR
NSAR Jul. 15 at 8:14 PM
$GUTS closing up 14% with that type of volume is very impressive. Now comes the upgrades and more volume coming in over the next couple days. 
1 · Reply
Merlintrader
Merlintrader Jul. 15 at 8:08 PM
$GUTS Fractyl Health Stock Hub - Revita, REMAIN-1 one-year randomized data, the De Novo path, Rejuva gene therapy and the 2026 catalysts https://www.merlintrader.com/fractyl-health-guts-stock-hub/
0 · Reply
Abetwit
Abetwit Jul. 15 at 7:27 PM
$GUTS I am still RED
0 · Reply
jmmoore4
jmmoore4 Jul. 15 at 7:10 PM
$GUTS Come on, buyers! Excellent news today! ⬆️
0 · Reply
Crypto9999
Crypto9999 Jul. 15 at 6:58 PM
$GUTS 🤑🤑🤑
0 · Reply
jmmoore4
jmmoore4 Jul. 15 at 6:18 PM
$GUTS Bull flagging! 🚩
0 · Reply